ReviewExpert opinion on therapeutic targets2019

The molecular rationale for therapeutic targeting of glutamine metabolism in pulmonary hypertension.

Thomas Bertero et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.